Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Effective treatments for severe alopecia areata are still lacking.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Oral ulcers are common in SLE patients and often link to other symptoms.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.